A gas chromatographic method is presented to measure blood, serum or plasma concentrations of more than 40 basic drugs. The sensitivity is 0·05 mg/L or less, which represents medium-high therapeutic and overdose concentrations, and in many instances the major active metabolites are also quantified. The paper describes a single step extraction from basic solution into n-butyl acetate containing maprotiline internal standard. Disposable glass tubes are used, with direct chromatography of the upper organic layer. GLC analysis is conducted for IOmin isothermally on a packed column (3% SP2250) with nitrogen-phosphorus detection. The coefficient of variation (CY) of the assay is between 2% and 5%, and data on the reproducibility of retention times are presented.
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Laboratory analysis is crucial to the diagnosis of poisoning. I) The approach at this Unit for basic drugs is initially to screen urine and/or gastric contents for the presence of compounds and their metabolites using a combination of capillary gas chromatography and thin layer chromatography.V Once identified, these compounds can be quantified in blood, plasma or serum using alternative techniques. When neither urine nor gastric contents is available, direct analysis of blood must be the first line of approach. In some instances analysis of gastric contents may be inappropriate (e.g. when drugs are administered by injection). Analysis solely of urine may also be misleading, since the presence or absence of drugs and metabolites neither confirms nor refutes recent overdosage: drugs ingested as long as 2 weeks previously may be detected, while drugs recently ingested may not yet have been excreted as, for instance, in shock when there is renal shutdown.' Urine results may also be confusing if several drugs with a large number of metabolites are involved. An accurate drug measurement in blood is often, therefore, essential to establish the correct diagnosis of poisoning.
This paper presents a simple effective extraction and rapid gas chromatographic method for the accurate determination of more than 40 basic Correspondence: Sheila Dawling, Poisons Unit, New Cross Hospital, Avonley Road, London SEI4 5ER, UK. drugs in blood, plasma or serum. It is also a valuable screening method for the detection and identification of basic drugs when urine or gastric contents are not available. Typical chromatograms obtained from plasma of poisoned patients are presented to illustrate the application of the method.
MATERIALS AND METHODS
Reagents N-butyl acetate and methanol were both HPLC grade (Rathburn, Walkerburn, UK). Analar grade 35% ammonia solution (BDH, Poole, UK) was diluted with distilled water and used as 4 Molar. Pure samples of drugs and metabolites were generously provided by manufacturers. Quantitative standards were prepared in blank serum, generally by dilution of a I g/L methanolic stock solution, and were frozen in 1-2mL aliquots. The internal standard maprotiline hydrochloride (Ciba-Geigy, Horsham, UK) was prepared as I g/L (free base equivalent) stock solution in methanol, and diluted to 6 mg/L in n-butyl acetate for use. These were stable for at least 2 years when stored at 4°C.
Instrumentation
A Hewlett-Packard 57lOA gas chromatograph fitted with a nitrogen-phosphorus detector was used (Hewlett-Packard, Winnersh, UK). The column oven was set isothermally at 270°C, and the injector and detector temperatures were 300°C. The silanized glass column (2-4m x 2 mm id) was packed with 3% SP2250 on Supelcoport (80-100 mesh) obtained from Supelchem (Sawbridgeworth, UK). The carrier gas was helium (30 mL/min), with hydrogen (2 mL/min) and air (55 mL/min) supplied to the detector. A Hewlett-Packard 3390 recording integrator was used to measure both retention time and area of any peaks produced. The maximum run time was IOmin (2'5 times the internal standard).
Sample preparation
Sample or standard (300 J.LL) was pipetted into a small glass test tube (60 x 7 mm Dreyers tube; S.A. Murray, Old Woking, UK). After addition of 100 J.LL 4 M ammonia solution and internal standard (50 J.LL of 6 mg/L maprotiline solution in n-butyl acetate), the tubes were vortex mixed for 30 s, and centrifuged for 60 s in an Eppendorf 5412 centrifuge at 9950 x g (Anderman, Kingston-Upon-Thames, UK). A 2J.LL portion of the upper organic phase was used for analysis.
Calibration
Identification of drugs was made by calculating their retention time relative to the internal standard maprotiline, and comparing these to the listed values for drugs shown in Table I . Construction of graphs of peak area ratio to internal standard of known amounts of drug standard versus concentration enabled quantification of sample concentrations. Duplicate analyses were made and the mean results taken. 0·77  0·78  0·78  0·79  0·80  0·80  0·80  0·81  0·83  0·84  0·86  0·89  0·93  0·97  1·10  1·12  1·16  1·19·  1·30  1·33  1·35  1·38  1·43  1-49  1·51  1·61  1·61  1·65  1,71  1·74  1·95·  2·01  2·15  2·15  2·37 ·Poor peak shape due to thermal instability. Inter-and intra-assay coefficients of variation for the method were calculated from 20 values each. The stability of the relative retention data was determined for five components by making 50 consecutive injections (intra-assay), and from 50 positive case sample injections made over a period of 2 years (inter-assay).
RESULTS
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DISCUSSION
The method described in this paper has been in routine use in this Unit for 3 years. Its value when used as a sequel to preliminary drug detection FIGURE 1. Chromatogram from plasma extract of a patient who had a cardiac arrest following a grand mal convulsion. Urine was not available at the time of analysis. Lignocaine and diazepam were given in treatment. Peaks are: (1) Lignocaine; (2) caffeine; (3) nortriptyline 4·2mg/L; (4) maprotiline internal standard; (5) 
The retention times of more than 40 basic drugs plus a number of their major active metabolites are listed in Table I . Using amitriptyline and nortriptyline as examples. calibration graphs passed through the origin and were linear over a 200-fold concentration range (0,05-10,0 mgjL). The limits of accurate measurement were generally less than 0·05 mgjL depending on the sensitivity of the detector to specific components. The within and between assay coefficients of variation (CV) were less than 5% for both amitriptyline and nortriptyline, and these are shown in Table 2 . The reproducibility of the retention data over time was excellent and these data are shown in Chromatogram from blood extract of a patient who died suddenly 5 days after admission to a psychiatric hospital. At the time ofdeath the drug treatment was methadone 25 mg, procyclidine 5 mg qds, chlorpromazine 300 mg qds and haloperidol 30 mg qds. Peaks are: (1) caffeine; (2) methadone Irl mgll.; (3) procyclidine 1·6 mzlL; (4) maprotiline internal standard; (5) chlorpromazine 3·5 mg/ L. and identification in urine or gastic contents has been clearly demonstrated, since the range of drugs covered includes the tricyclic and related antidepressants, some antihistamines, benzodiazepines, opioids and cardioactive drugs, all of which are commonly taken in overdose. While the benzodiazepines have been included here, methods using electron capture detection are more selective and therefore preferable." Similarly propoxyphen and its N-demethylated metabolite decompose on the column producing asymmetrical peaks, and therefore these are more accurately measured by HPLC. 7 Direct injection of the solvent onto the gas chromatograph is easy since the solvent layer is above the aqueous phase. The use of disposable tubes avoids possible contamination from inadequate washing, and no special pre-treatment or washing procedures are required to FIGURE 3. Chromatogram from plasma extract of a patient who took an overdose of antihistamines. Metronidazole was given in treatment. Peaks are: (1) metronidazole 3·9 mg/ L; (2) caffeine; (3) brompheniramine 0·92mg/L; (4) promethazine 0·32mg/L; (5) maprotiline internal standard.
eliminate adhesion of drugs to the tubes. The lack of an evaporation step also eliminates any loss of drug through adhesion and evaporation. The sensitivity of the method described is more than adequate for the purposes of clinical and forensic toxicology. In most instances, a 300 J1L sample gives a good response for medium to high therapeutic concentrations. The sample volume used for the assay can be adjusted according to the relative toxicity of the drug in question; for example 20 J1L for lignocaine and SOO J1L for benzhexol. Using the mildly basic conditions described here for the extraction, even post mortem blood can be quite readily mixed. Use of too strong a base (for example sodium hydroxide) with whole blood denatures the sample and prevents adequate mixing. However, although the method is equally applicable to plasma or whole blood, the interpretation of results must take account of the extent to which the drug is taken into red cells.
The relative retention data produced by this method are remarkably consistent. The relatively poor performance (inter-assay CV > 1,0%) of early eluting components, such as caffeine and amitriptyline, results in part from the fact that the gas chromatograph run and the integrator are started independently of each other. The data in Table 3 were compiled over a period of2 years during which three different columns were used. This means that the sytem can be applied as a primary screen on blood when urine or gastric contents are not available or, more rarely, a urine screen has proved negative, but grounds remain for suspecting poisoning. However, its use in this respect is limited by the resolving power of the column. This could be improved by progressing to a longer column (3,6 m is the maximum length for convenient use). Alternatively, extracts could be chromato graphed at the same time on a second column with a different polarity. A good companion column to 3% SP2250 is 3% .OVI and both can be operated simultaneously in the same gas chromatograph. A further approach would be to screen the blood extracts using a capillary column and temperature programming. The superior separating power and inate reproducibility of capillary columns provides an ideal means of detecting and identifying drugs and metabolites in urine or gastric contents. However, attempts to apply this technique to the analysis of large numbers of plasma or blood samples have highlighted several problems. First, the requirement for temperature programming inevitably demands a long run time, particularly to separate the large number of basic drugs in the mid-part of the retention range (i.e. where the tricyclic antidepressants are located). Additional time is also required for cooling before the next analysis can proceed. Since the method presented here involves only a single step extraction, and chromatographic analysis time is 10min at most, a single sample with a three point calibration, all prepared in duplicate, can be analysed in about I h. Secondly, the use of blood or plasma with some types of cold on-column injectors results in the accumulation of lipid material on the top of the column which causes a marked deterioration in performance after five or six injections. Heated injectors are much more robust in this respect, but their use in the splitless injection mode for quantification of drugs can be hampered by carry-over of components into the next injection.
In summary, this method has proved to be an invaluable addition to the routine screening procedures used in forensic and clinical toxicology in this laboratory since it provides vital evidence in the diagnosis of poisoning within a clinically relevant time scale. Moreover it provides reliable drug concentration data on post mortem blood samples from suicide victims. It is ideally used as a sequel to drug identification in urine or stomach contents.
